This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Posted 13 Sep 2013

Updated: A proposed regulatory path for antibacterial drug development

About the author

John Rex

John Rex

View author

Follow AstraZeneca: